Trial intelligence / Profile preview

Pagoclone in Men With Primary Premature Ejaculation

NCT00370981Phase 2Completed

Sponsor
Endo International plc
Start
Jul 2006
Primary completion
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pagoclone in premature ejaculation (PE), sponsored by Endo International plc. Started Jul 2006; status: completed.

02

Drugs

pagoclone
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT00370981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00370981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call